The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lercaril 10 mg/10 mg film-coated tablets



Recordati Ireland LimitedPA1404/002/001

Main Information

Trade NameLercaril 10 mg/10 mg film-coated tablets
Active SubstancesLercanidipine hydrochloride
Enalapril maleate
Dosage FormFilm-coated tablet
Licence HolderRecordati Ireland Limited
Licence NumberPA1404/002/001

Group Information

ATC CodeC09BB ACE inhibitors and calcium channel blockers
C09BB02 enalapril and lercanidipine

Status

License statusAuthorised
Licence Issued22/08/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back